Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Proton Treatment and Research Center
AddedFeb 18, 2024
UpdatedJun 18, 2026
Proton Treatment and Research Center

Proton Treatment and Research Center

California-based medical organization specializing in advanced proton radiation therapy for prostate cancer.

HQ
Loma Linda, CA, US
Founded
1990
Overview
Compare
Fundraising
Employees
Website

Founded in Loma Linda, California, the Proton Treatment and Research Center is dedicated to advancing the development and application of proton radiation therapy, particularly for prostate cancer. The organization’s core mission is to enhance patient care and improve the quality of life for men with prostate cancer through dedicated research and cutting-edge treatment options. They offer specialized proton radiation therapy, which is known for its precision and reduced side effects compared to traditional radiation treatments.

The center has garnered attention for its innovative approach and commitment to research, contributing significantly to the field of oncology. Notable affiliated individuals include leading oncologists and medical researchers specializing in proton therapy. The Proton Treatment and Research Center has achieved recognition for its high success rates and patient satisfaction, making a substantial impact on cancer treatment protocols and patient outcomes.

Similar Companies

Proton Therapy USA logo

Proton Therapy USA

Protom International logo

Protom International

Mevion Medical Systems logo

Mevion Medical Systems

mevion.com

bioProtonics logo

bioProtonics

bioprotonics.com

Core Oncology logo

Core Oncology

Protea Medical logo

Protea Medical

protealife.com

Latest Medical logo

Latest Medical

ProstaGene logo

ProstaGene

ProNova Solutions logo

ProNova Solutions

The Oncology Institute logo

The Oncology Institute

TreatmentX logo

TreatmentX

treatmentx.com

Oncology Honduras logo

Oncology Honduras

Oncternal Therapeutics logo

Oncternal Therapeutics

oncternal.com

Oncora Medical logo

Oncora Medical

oncoramedical.com

Advanced Cancer Therapeutics logo

Advanced Cancer Therapeutics

Proton Treatment and Research Center - Quick Facts

Who are Proton Treatment and Research Center's competitors?

Companies similar to Proton Treatment and Research Center include Proton Therapy USA, Protom International, Mevion Medical Systems and bioProtonics.

When was Proton Treatment and Research Center founded?

Proton Treatment and Research Center was founded in 1990.

Where is Proton Treatment and Research Center's headquarters located?

Proton Treatment and Research Center's headquarters is located in Loma Linda, CA, US.

When was Proton Treatment and Research Center's last funding round?

Proton Treatment and Research Center's most recent funding round was for $125k (USD) in January 2022.

How much has Proton Treatment and Research Center raised to-date?

As of Jan 19, 2022, Proton Treatment and Research Center has raised a total of $125k (USD).

How many employees does Proton Treatment and Research Center have?

Proton Treatment and Research Center has 30 employees as of Feb 4, 2024.

Proton Treatment and Research Center - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Treatment
Tags
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified